Australia Gets Psychedelics Research Institute With $29M In Funding From Undisclosed North American Company

A new research institute called The Psychae Institute was announced on Friday, and will focus on advancing psychedelics research in Australia.

The newly-founded research organization plans to launch clinical research into psilocybin, DMT and MDMA, among others molecules.

According to The Sydney Morning Herald, the Melbourne-based institute is lifting off with initial funding of AU$40 million ($29.3 million) from an undisclosed North American biotechnology company.

Funding will be delivered over five years. The institute expects to receive more funding from philanthropic donations, private investment and government grants.

The unrevealed backing company expressed an intention to remain undisclosed as part of its strategy to secure private investment.

“There’s a lot of people where [pharmaceutical drugs] don’t work very well, if at all, or they have significant side effects. There’s a desperate need for new types of treatments,” said Psychae Institute co-director Daniel Perkins, an adjunct associate professor at Swinburne University and the University of Melbourne.

According to the professor, Australia is the perfect place to progress clinical trials as it requires regulatory notifications instead of approvals, unlike many other countries like the U.S. 

The institute will also oversee clinical studies in the U.K., Canada, Europe and Brazil and plans to launch its own clinical research in early 2022.

Photo: Melbourne skyline Denise Jans on Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisMarketsPsychedelicsThe Psychae Institute
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!